Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s13046-018-0719-1 http://scihub22266oqcxt.onion/10.1186/s13046-018-0719-1 C5850913!5850913!29534749     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Exp+Clin+Cancer+Res 2018 ; 37 (ä): ä Nephropedia Template TP {{tp|p=29534749|t=2018. Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities |pdf=|usr=}}{{29534749}} gab.com Text Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities JO: J Exp Clin Cancer Res http://www.kidney.de/pget.php?&tw=1&pmid=29534749 #FOAvip Developing drugs that target KRAS, the most frequently mutated oncogene in cancer, has not been successful despite much concerted efforts dedicated towards it in the last thirty years. Considering the key role this driver oncogene plays, the pharmacological drugging of KRAS remains a key challenge for cancer research. In this review, we highlight the emerging experimental strategies for blocking KRAS function and signaling and its direct targeting. We also report on the results in this field of research produced by our group. Twit Text FOAVip Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities ????J Exp Clin Cancer Res http://www.kidney.de/pget.php?&tw=1&pmid=29534749 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29534749 #FOAvip English Wikipedia <ref>{{Cite pmid|29534749}}</ref> Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities #MMPMID29534749 Porru M; Pompili L; Caruso C; Biroccio A; Leonetti C J Exp Clin Cancer Res 2018[]; 37 (ä): ä PMID29534749show ga Developing drugs that target KRAS, the most frequently mutated oncogene in cancer, has not been successful despite much concerted efforts dedicated towards it in the last thirty years. Considering the key role this driver oncogene plays, the pharmacological drugging of KRAS remains a key challenge for cancer research. In this review, we highlight the emerging experimental strategies for blocking KRAS function and signaling and its direct targeting. We also report on the results in this field of research produced by our group. äTargeting KRAS in metastatic colorectal cancer: current strategies and(epmc).pdf DeepDyve Pubget Overpricing